Consensus
The community is strongly leaning bearish on AstraZeneca at 22%, based on 3 forecasts. Forecasters are in moderate agreement.
Resolves YES if AstraZeneca's closing price on the resolve date is at or above $179.
Share your read on this question — the best forecasters show their work.
See the whole azn discussion →